A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Study sponsor: Mineralys Therapeutics Inc. · MLYS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-01-15Actual
Enrollment · participants285Actual
Source updated2026-01-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.